The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World

被引:0
|
作者
Stroo, Jasmijn [1 ]
Lepolder, Michaela [1 ]
Murk, Jean-Luc [2 ]
Rijkers, Ger T. [1 ]
机构
[1] Univ Coll Roosevelt, Sci Dept, NL-4331 CB Middelburg, Netherlands
[2] St Elizabeth Hosp, Microvida Lab Med Microbiol & Immunol, NL-5022 GC Tilburg, Netherlands
关键词
COVID pass; SARS-CoV-2 antigen test; SARS-CoV-2; antibodies; societal restrictions;
D O I
10.3390/vaccines11091407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To control the COVID-19 pandemic, many countries implemented vaccination and imposed societal restrictions both at the national level and for international travel. As a check of corona status, COVID passes have been issued. A COVID pass could be obtained when either fully vaccinated against COVID-19, or after recovering from a documented COVID-19 episode, or after a recent (24-48 h) negative SARS-CoV-2 antigen test. A global analysis of SARS-CoV-2 immune status determined by past infection and/or vaccination, vaccination rates, as well as societal restrictions in controlling the COVID-19 pandemic is presented. The data show that across the world, vaccination was more effective in reducing SARS-CoV-2 infections with the delta variant than the omicron variant. Strict societal restrictions could control spread of the virus, but relief of the restrictions was associated with an increase in omicron infections. No significant difference in SARS-CoV-2 infections were found when comparing countries or territories which did or did not implement a COVID pass.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The Economic Impact of the SARS-COV-2 (COVID-19) Pandemic in Spain
    Pinilla, Jaime
    Barber, Patricia
    Vallejo-Torres, Laura
    Rodriguez-Mireles, Silvia
    Lopez-Valcarcel, Beatriz G.
    Serra-Majem, Luis
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (09)
  • [22] Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease
    Prakash, Hridayesh
    Upadhyay, Dilip
    Bandapalli, Obul Reddy
    Jain, Aklank
    Kleuser, Burkhard
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2021, 152
  • [23] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    VACCINES, 2021, 9 (03) : 1 - 13
  • [24] Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
    Heedo Park
    Mee Sook Park
    Jong Hyeon Seok
    Jaehwan You
    Jineui Kim
    Jeonghun Kim
    Man-Seong Park
    Journal of Microbiology, 2022, 60 : 308 - 320
  • [25] Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
    Park, Heedo
    Park, Mee Sook
    Seok, Jong Hyeon
    You, Jaehwan
    Kim, Jineui
    Kim, Jeonghun
    Park, Man-Seong
    JOURNAL OF MICROBIOLOGY, 2022, 60 (03) : 308 - 320
  • [26] The immune response to SARS-CoV-2 and COVID-19 immunopathology -- Current perspectives
    Boechat, J. L.
    Chora, I.
    Morais, A.
    Delgado, L.
    PULMONOLOGY, 2021, 27 (05): : 423 - 437
  • [27] Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
    Lowery, Shea A.
    Sariol, Alan
    Perlman, Stanley
    CELL HOST & MICROBE, 2021, 29 (07) : 1052 - 1062
  • [28] The interplay between the immune system and SARS-CoV-2 in COVID-19 patients
    Shabbir, Sana
    Raza, Muhammad Hassan
    Arshad, Muhammad
    Khan, Muhammad Jawad
    ARCHIVES OF VIROLOGY, 2021, 166 (08) : 2109 - 2117
  • [29] Considering innate immune responses in SARS-CoV-2 infection and COVID-19
    Diamond, Michael S.
    Lambris, John D.
    Ting, Jenny P.
    Tsang, John S.
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (08) : 465 - 470
  • [30] Considering innate immune responses in SARS-CoV-2 infection and COVID-19
    Michael S. Diamond
    John D. Lambris
    Jenny P. Ting
    John S. Tsang
    Nature Reviews Immunology, 2022, 22 : 465 - 470